Original Research

Published on 15 Aug 2023

Analysis of adverse drug reactions/events of cancer chemotherapy and the potential mechanism of Danggui Buxue decoction against bone marrow suppression induced by chemotherapy

in Pharmacology of Anti-Cancer Drugs

Bin Yu
Xida Yan
Yuanying Zhu
Ting Luo
Muhammad Sohail
Hong Ning
Hui Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227528

1,997 views
1 citation

Original Research

Published on 14 Aug 2023

Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study

in Pharmacology of Anti-Cancer Drugs

Yongbao Wei
Ruochen Zhang
Chenbo Yu
Zhiwei Hong
Le Lin
Tao Li
Jianhui Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1230395

4,631 views
14 citations

Review

Published on 14 Aug 2023

Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives

in Pharmacology of Anti-Cancer Drugs

Alireza Mafi
Hamidreza Rismanchi
Yasaman Gholinezhad
Mohaddese Malek Mohammadi
Vahide Mousavi
Seyed Ali Hosseini
Yaser Eshaghi Milasi
Russel J. Reiter
Behrooz Ghezelbash
Malihe Rezaee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1224151

5,089 views
5 citations

Original Research

Published on 11 Aug 2023

Ceruloplasmin is associated with the infiltration of immune cells and acts as a prognostic biomarker in patients suffering from glioma

in Pharmacology of Anti-Cancer Drugs

Miaomiao Jia
Tianyu Dong
Yangyang Cheng
Fanghao Rong
Jiamin Zhang
Wei Lv
Shuman Zhen
Xianxian Jia
Bin Cong
Yuming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249650

2,417 views
2 citations

Original Research

Published on 11 Aug 2023

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients

in Pharmacology of Anti-Cancer Drugs

Giuseppe Corona
Emanuela Di Gregorio
Angela Buonadonna
Davide Lombardi
Simona Scalone
Agostino Steffan
Gianmaria Miolo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212634

1,797 views
4 citations

Review

Published on 11 Aug 2023

Chemotherapeutic drugs for soft tissue sarcomas: a review

in Pharmacology of Anti-Cancer Drugs

Zhichao Tian
Weitao Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199292

5,922 views
15 citations

Original Research

Published on 10 Aug 2023

Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours

in Pharmacology of Anti-Cancer Drugs

Samantha L. S. Ellis
Sarah Dada
Lilian L. Nohara
Iryna Saranchova
Lonna Munro
Cheryl G. Pfeifer
Brett A. Eyford
Tunc Morova
David E. Williams
Ping Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119620

1,529 views
2 citations

Case Report

Published on 08 Aug 2023

Case report: Immunotherapy plus chemotherapy and stereotactic ablative radiotherapy (ICSABR): a novel treatment combination for Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Ruizhen Li
Ke Cheng
Xiaofen Li
Chen Chang
Wanrui Lv
Li Xiaoying
Pei Zhang
Heqi Yang
Dan Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1147449

1,663 views
3 citations

Original Research

Published on 07 Aug 2023

Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma

in Pharmacology of Anti-Cancer Drugs

Quanqiang Wang
Misheng Zhao
Tianyu Zhang
Bingxin Zhang
Ziwei Zheng
Zhili Lin
Shujuan Zhou
Dong Zheng
Zixing Chen
Sisi Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203125

2,090 views

Original Research

Published on 07 Aug 2023

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives

in Pharmacology of Anti-Cancer Drugs

Xi-Xi Hou
Long-Fei Mao
Yajie Guo
Chaoxuan Lou
Lan Wang
Rui-Fang Li
Huili Wang
San-Qiang Li
Jian-Xue Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1238587

1,237 views

Review

Published on 07 Aug 2023

Advances in the treatment of pancreatic cancer with traditional Chinese medicine

in Pharmacology of Anti-Cancer Drugs

Yanhua Zhang
Hui Xu
Yue Li
Yang Sun
Xiaochun Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1089245

8,845 views
1 citation

Review

Published on 07 Aug 2023

The effect of liver disease on hepatic microenvironment and implications for immune therapy

in Pharmacology of Anti-Cancer Drugs

Zachary J. Brown
Samantha M. Ruff
Timothy M. Pawlik

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1225821

4,441 views
6 citations

Editorial

Published on 04 Aug 2023

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy

in Pharmacology of Anti-Cancer Drugs

Chunxue Zhang
Runbin Sun
Bo Kong
Rong Hu
Qianming Du

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256643

1,236 views

Original Research

Published on 04 Aug 2023

Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma

in Pharmacology of Anti-Cancer Drugs

Xiwen Tong
Jie Jin
Bin Xu
Shuai Su
Li Li
Mengyuan Li
Yizhou Peng
Xia Mao
Wei Huang
Donghua Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217701

2,335 views
1 citation

Review

Published on 03 Aug 2023

Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent

in Pharmacology of Anti-Cancer Drugs

Vijay Laxmi Trivedi
Ruchi Soni
Praveen Dhyani
Priyanka Sati
Silvia Tejada
Antoni Sureda
William N. Setzer
Ahmad Faizal Abdull Razis
Babagana Modu
Monica Butnariu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1187181

12,723 views
9 citations

Review

Published on 02 Aug 2023

Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance

in Pharmacology of Anti-Cancer Drugs

Xixia Zhang
Xiaofeng Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1230822

3,794 views
6 citations

Navigation group

Articles

Analysis of adverse drug reactions/events of cancer chemotherapy and the potential mechanism of Danggui Buxue decoction against bone marrow suppression induced by chemotherapy

Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study

Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives

Ceruloplasmin is associated with the infiltration of immune cells and acts as a prognostic biomarker in patients suffering from glioma

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients

Chemotherapeutic drugs for soft tissue sarcomas: a review

Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours

Case report: Immunotherapy plus chemotherapy and stereotactic ablative radiotherapy (ICSABR): a novel treatment combination for Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma

Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives

Advances in the treatment of pancreatic cancer with traditional Chinese medicine

The effect of liver disease on hepatic microenvironment and implications for immune therapy

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy

Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma

Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent

Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance